Biotechnology and nanotechnology

Filter results by

Search Help
Currently selected filters that can be removed

Keyword(s)

Type

1 facets displayed. 0 facets selected.

Geography

2 facets displayed. 0 facets selected.
Sort Help
entries

Results

All (6)

All (6) ((6 results))

  • Articles and reports: 88-003-X20040037432
    Geography: Canada
    Description:

    This article is based on a recent series of interviews with leaders of high growth biotechnology firms. It highlights the importance of financing, management strategies and qualified personnel for achieving high growth.

    Release date: 2004-10-29

  • Articles and reports: 88F0006X2004017
    Description:

    Using data from the 1997 Biotechnology Firm Survey and the 1999 and 2001 cycles of the Biotechnology Use and Development Survey, this article portrays the evolution of key indicators of Canadian biotechnology companies from 1997 to 2001.

    Release date: 2004-10-22

  • Articles and reports: 88-001-X20040077864
    Description:

    Data on science and technology (S&T) expenditures and person-years allocated to biotechnology for the year 2002-2003 were collected from selected federal departments and agencies. The criterion for selection was significant activity in this field. Survey results contribute to the work of the Canadian Biotechnology Strategy. The data collected for biotechnology are composed of research and development (R&D) and related scientific activities (RSA) expenditures, for intramural and extramural activities, by performer, and also the person-years associated with these activities.

    Release date: 2004-07-19

  • Articles and reports: 88-003-X20040026930
    Geography: Canada
    Description:

    Biotechnology activity in Canada is flourishing. The total number of biotechnology firms has been continually increasing in recent years. This expansion can also be observed from the changes in revenues generated by biotechnology. Research and development (R&D) efforts are starting to bear fruit and this is reflected in the revenue ratio on R&D.

    Release date: 2004-06-30

  • Articles and reports: 88-003-X20040016791
    Geography: Canada, Province or territory
    Description:

    Data from the 2001 Biotechnology Use and Development Survey reveal that there are 133 biotechnology Canadian-based firms manufacturing or developing bioproducts. These mostly private 'home-grown' firms, located in Quebec, British Columbia and Ontario, are operating across all economic sectors. The largest share of their combined portfolio of 805 bioproducts is at the commercialization stage. Bioprocessing-based bioproducts (products developed or made using enzymes and bacteria culture) lead the way.

    Release date: 2004-03-05

  • Articles and reports: 88F0006X2004006
    Description:

    Biotechnology is a pervasive technology used in several industrial sectors, making collecting sound data a real challenge. This paper describes the methodology of the Biotechnology Use and Development Survey. Some of the specific issues dealt with are the definitions of biotechnology and innovative biotechnology firms, the target population, sampling, data collection procedures, and data quality evaluation.

    Release date: 2004-03-05
Data (0)

Data (0) (0 results)

No content available at this time.

Analysis (6)

Analysis (6) ((6 results))

  • Articles and reports: 88-003-X20040037432
    Geography: Canada
    Description:

    This article is based on a recent series of interviews with leaders of high growth biotechnology firms. It highlights the importance of financing, management strategies and qualified personnel for achieving high growth.

    Release date: 2004-10-29

  • Articles and reports: 88F0006X2004017
    Description:

    Using data from the 1997 Biotechnology Firm Survey and the 1999 and 2001 cycles of the Biotechnology Use and Development Survey, this article portrays the evolution of key indicators of Canadian biotechnology companies from 1997 to 2001.

    Release date: 2004-10-22

  • Articles and reports: 88-001-X20040077864
    Description:

    Data on science and technology (S&T) expenditures and person-years allocated to biotechnology for the year 2002-2003 were collected from selected federal departments and agencies. The criterion for selection was significant activity in this field. Survey results contribute to the work of the Canadian Biotechnology Strategy. The data collected for biotechnology are composed of research and development (R&D) and related scientific activities (RSA) expenditures, for intramural and extramural activities, by performer, and also the person-years associated with these activities.

    Release date: 2004-07-19

  • Articles and reports: 88-003-X20040026930
    Geography: Canada
    Description:

    Biotechnology activity in Canada is flourishing. The total number of biotechnology firms has been continually increasing in recent years. This expansion can also be observed from the changes in revenues generated by biotechnology. Research and development (R&D) efforts are starting to bear fruit and this is reflected in the revenue ratio on R&D.

    Release date: 2004-06-30

  • Articles and reports: 88-003-X20040016791
    Geography: Canada, Province or territory
    Description:

    Data from the 2001 Biotechnology Use and Development Survey reveal that there are 133 biotechnology Canadian-based firms manufacturing or developing bioproducts. These mostly private 'home-grown' firms, located in Quebec, British Columbia and Ontario, are operating across all economic sectors. The largest share of their combined portfolio of 805 bioproducts is at the commercialization stage. Bioprocessing-based bioproducts (products developed or made using enzymes and bacteria culture) lead the way.

    Release date: 2004-03-05

  • Articles and reports: 88F0006X2004006
    Description:

    Biotechnology is a pervasive technology used in several industrial sectors, making collecting sound data a real challenge. This paper describes the methodology of the Biotechnology Use and Development Survey. Some of the specific issues dealt with are the definitions of biotechnology and innovative biotechnology firms, the target population, sampling, data collection procedures, and data quality evaluation.

    Release date: 2004-03-05
Reference (0)

Reference (0) (0 results)

No content available at this time.

Date modified: